PMID: 12668217
Our specially formulated IV Drip blends are designed by experts and backed by science to deliver these essential nutrients directly, supporting your hormones and helping you feel your best every day
Naltrexone, approved in 1984, introduced a non-opioid antagonist that blocked the effects of opioids but required full detoxification before initiation, limiting its early use
In 2023, the FDA moved 19 popular peptides to Category 2, citing concerns about immunogenicity risk, peptide-related impurities, and limited human safety data
Notably, drug candidates did not negatively impact on cell viability or cause membrane damage
Preserves physiologic feedback, reducing risk of supraphysiologic GH or IGF1 levels compared to exogenous GH [6]